Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate |
2015-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-107250360-B |
titleOfInvention |
c-Rel specific siRNA and its application in preventing and treating autoimmune psoriasis |
abstract |
Provided are c-Rel-specific siRNA and its application for preventing and treating autoimmune psoriasis. Specifically, the c-Rel-specific siRNA has the sequence shown in SEQ ID Nos. 1-2 or SEQ ID Nos. 3-4, and the present invention adopts c-Rel-specific small interfering ribonucleic acid to inhibit c-Rel Biosynthesis of IL-23/IL-17A inflammatory axis-related inflammatory factors to prevent and treat autoimmune psoriasis. |
priorityDate |
2015-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |